Fysiske bivirkninger ved AAS

AIACHE AE. Surgical treatment of gynecomastia in the body builder. Plastic reconstr surg 1989 83:61-66.

 

AKHTER J, HYDER S, AHMED M. Cerebrovascular accident associated with anabolic steroid use in a young man. Neurology 1994 44:2405-2406.

 

ALÉN M, HÄKKINEN K. Physical health and fitness of an elite bodybuilder during 1 year of self-administration of testosterone and anabolic steroids: A case study. Int J Sports Med 1985 6:24-29.

 

ALÉN M, RAHKILA P. Reduced high-density lipoprotein-cholesterol in power athletes: use of male sex hormone derivates, an atherogenic factor. Int J Sports Med 1984 5:341-342 .

 

ALÉN M, RAHKILA P, MARNIEMI J. Serum lipids in power athletes self-administering testosterone and anabolic steroids. Int J Sports Med 1985a 6:139-144.

 

ALÉN M, RAHKILA P, REINILÄ M, VIHKO R. Androgenic-anabolic steroid effects on serum thyroid, pituitary and steroid hormones in athletes. Am J Sports Med 1987 15:357-361.

 

ALÉN M, REINILÄ M, VIHKO R. Response of serum hormones to androgen administration in power athletes. Med Sci Sports Exerc 1985b 17:354-359.

 

ALÉN M, SUOMINEN J. Effect of androgenic and anabolic steroids on spermatogenesis in power athletes. Int J Sports Med 1984 5:189-192.

 

ANSELL JE, TIARKS C, FAIRCHILD VK. Coagulation abnormalities associated with the use of anabolic steroids. Am Heart J 1993 125:367-371.

APPLEBY M, FISHER M, MARTIN M. Myocardial infarction, hyperkalaemia and ventricular tachycardia in a young male body-builder. Int J Cardiol 1994 44:171-174.

 

BAGATELL CJ, HEIMAN JR, MATSUMOTO AM, RIVIER JE, BREMNER WJ. Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men. J Clin Endocrinol Metab 1994 79:561-567.

 

BEHRE HM, BOHMEYER J, NIESCHLAG E. Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls. Clin Endocrinol 1994 40:341-349 .

 

BJÖRNTORP P. Androgens, the metabolic syndrome, and non-insulin-dependent diabetes mellitus. Ann NY Acad Sci 1993 676:242-252.

 

BOWMAN SJ, TANNA S, FERNANDO S, AYODEJI A, WEATHERSTONE RM. Anabolic steroids and infarction. Br Med J 1989 299:632.

 

CABASSO A. Peliosis hepatis in a young adult bodybuilder. Med Sci Sports Exerc 1994 26:2-4.

 

COHEN JC, HICKMAN R. Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids. J Clin Endocrinol Metab 1987 64:960-963.

 

COHEN MS, SANCHEZ RL. Hemorrhagic urethritis in female-to-male transsexual. Urology 1987 30:583-585.

 

COHEN LI, HARTFORD CG, ROGERS GG. Lipoprotein (a) and cholesterol in body builders using anabolic androgenic steroids. Med Sci Sports Exerc 1996 28:176-179 .

 

CREAGH TM, RUBIN A, EVANS DJ. Hepatic tumours induced by anabolic steroids in an athlete. J Clin Pathol 1988 41:441-443.

 

DEWHURST J, GORDON RR. Compensation from medical mishap. Lancet 1984 1226.

 

DEYSSIG R, WEISSEL M. Ingestion of androgenic-anabolic steroid induces mild thyroidal impairment in male body builders. J Clin Endocrinol Metab 1993 76:1069-1071.

 

DICKERMAN RD, SCHALLER F, PRATHER I, MCCONATHY WJ. Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 1995 86:172-173 .

 

FASS 1996. Läkemedelsinformation AB.

 

FERENCHICK GS. Anabolic/androgenic steroid abuse and thrombosis: is there a connection? Med Hypotheses 1991 35:27-31.

 

FERENCHICK GS, ADELMAN S. Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 1992 124:507-508

 

FERENCHICK GS, SCHWARTZ D, BALL M, SCHWARTS K. Androgenic-anabolic steroid abuse and platelet study in weight lifters. Am J Mec Sci 1992 303:78-82.

 

FORBES GM, BRAMSTON BA, COLLINS BJ. Anabolic steroid hepatotoxicity: lessons to be learnt? Aust NZ J Med 1993 23:309-310.

 

FRANKLE MA, EICHBERG R, ZACHARIAH SB. Anabolic androgenic steroids and a stroke in an athlete: case report. Arch Physical Med Rehab 1988 69:632-633.

 

FREEMAN BJC, ROOKER GD. Spontaneous rupture of the anterior cruciate ligament after anabolic steroids. Br J Sports Med 1995 29:274-275.

 

FRIEDL KE. Effects of anabolic steroids on physical health. In: Anabolic Steroids in Sport and Exercise, Yesalis CE, (ed), Human Kinetics Publishers, Champaign, Illinois, USA. 993 pp. 107-150.

 

FRIEDL KE, JONES RE, HANNAN JR CJ, PLYMATE SR. The administration og pharmacological doses of testosterone or 19-nortestosterone to normal men is not associated with increased insulin secretion or impaired glucose tolerance. J Clin Endocrinol Metab 1989 68:971-975.

 

FRIEDL KE, HANNAN JR CJ, JONES RE, PLYMATE SR. High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered. Metabolism. 1990 Jan;39(1):69-74.

 

GARRIGUES GV, BERENGUER L, PONCÉ GJ, MARTÍN MR. A non-C17-alkylated steroid and long-term cholestasis. Ann Intern Med 1986 104:135-136.

 

GERRITSMA EJ, BROCAAR MP, HAKKESTEEGT MM, BIRKENHÄGER JC. Virilization of the voice in post-menopausal women due to the anabolic steroid nandrolone decanoate (Decadurabolin). The effects of medication for one year.
Clin Otolaryngol. 1994 Feb;19(1):79-84.

 

GITTES RF. Carcinoma of the prostate.
N Engl J Med. 1991 Jan 24;324(4):236-45 .

 

GLAZER G. Atherogenic effects of anabolic steroids on serum lipid levels.
Arch Intern Med. 1991 Oct;151(10):1925-33.

 

GLAZER G, SUCHMAN AL. Lack of demonstrated effect of nandrolone on serum lipids.
Metabolism. 1994 Feb;43(2):204-10.

 

GLUUD C, HENRIKSEN JH. Liver haemodynamics and function in alcoholic cirrhosis. Relation to testosterone treatment and ethanol consumption.
J Hepatol. 1987 Apr;4(2):168-73.

 

GLUUD C CHRISTOFFERSEN P, ERIKSEN J, WANTZIN P, KNUDSEN BB. No effect of long-term oral testosterone treatment on liver morphology in men with alcoholic cirrhosis.
Am J Gastroenterol. 1987 Jul;82(7):660-4.

 

GOLDMAN B. Liver carcinoma in an athlete taking anabolic steroids.
J Am Osteopath Assoc. 1985 Feb;85(2):56.

 

GRUMBACH MM, DUCHARME JR. The effects of androgens on fetal sexual development. Androgen induced female pseudohermaphrodism. Fertil Steril 1960 11:157-180.

 

HALPERN AA, NAGEL DA. Bilateral compartment syndrome associated with adrogen therapy. Clin Orthop Rel Res 1977 128:243-246.

 

HENRION R, MANDELBROT L, DELFIEU D. Contamination par le VIH á la suite d’injections d’anabolisants. Presse Medicale 1992 21:218.

 

HOBBS CJ, PLYMATE SR, ROSEN CJ, ADLER RA. Testosterone administration increases insulin-like growth factor-I levels in normal men. J Clin Endocrinol Metab 1993 77:776-779.

 

HOLMÄNG S, MÅRIN P, LINDSTEDT G, HEDELIN H. Effect of long-term oral testosterone udecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonal middle-aged men. Prostate 1993 23:99-106.

 

HUIE MJ. An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sports Exerc 1994 26:408-413.

 

JAILLARD AS, HOMMEL M, MALLARET M. Venous sinus thrombosis associated with androgens in healthy young man. Strole 1994 25:212-213.

 

KENNEDY MC, CORRIGAN AB, PILBEAM ST. Myocardial infarction and cerebral haemorrhage in young body builder taking anabolic steroids. Aust NZ J Med 1993 23:713 .

 

KENNEDY MC, LAWRENCE C. Anabolic steroid abuse and cardiac death. Med J Aust 1993 158:346-348.

 

KIRÁLY CL. Androgenic-anabolic steroid effects on serum and skin surface lipids, on red cells, and on liver enzymes. Int J Sports Med 1988 9:249-252.

 

KIRÁLY CL, ALÉN M, RAHKILA P, HORSMANHEIMO M. Effect of androgenic and anabolic steroids on the sebaceous gland in power athletes. Acta Derm Venereol (stockh) 1987a 67:36-40.

 

KIRÁLY CL, COLLAN Y, ALÉN M. Effect of testosterone and anabolic steroids on the size of sebaceous glands in power athletes. Am J Dermatopathol 1987b 9:515-519.

 

KIRÁLY CL, ALÉN M, KORVOLA J, HORSMANHEIMO M. The effect of testosterone and anabolic steroids on the skinsurface lipids and the population of propionibacteria acnes in young postpubertal men. Acta Derm Venereol (stockh) 1988 68:21-26.

 

KNUTH UA, MANIERA H, NIESCHLAG E. Anabolic steroids and semen parameters in bodybuilders. Acta Endocrinol 1989 120(Suppl 1):121-122.

 

KRUSKEMPER HL. Anabolic steroids. Academic press, New York, USA. 1968 pp 1-236.

 

LANE PR, MASSEY KL, WOROBETZ LJ, JUTRAS MN, HULL PR. Acute hereditary coproporphyria induced by the androgenic/anabolic steroid methandrostenolone (Dianabol). J AM Acad Dermatol 1994 30:308-312.

 

LAROCHE GP. Steroids anabolic drugs and arterial complications in an athlete-a case history. Angiology 1990 41:964-969.

 

LASETER JT, RUSSELL JA. Anabolic steroid-induced tendon pathology: a review of the literature. Med Sci Sports Exerc 1991 23:1-3.

 

LENDERS JW, DEMACKER PN, VOS JA, JANSEN PL, HOITSMA AJ, VAN ‘T LAAR A, THIEN T. Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur body builders. Int J Sports Med 1988 9:19-23.

 

LJUNGQVIST A. Doping – ett missbruksproblem. In: Medicinsk Årbog, Munksgaard, Köpenhamn 1991, pp 123-130.

 

LJUNGSTRÖM KG, BARK S, FORSGREN L. Stasicterus orsakad av anabola steroider. Läkartidningen 1985 82:4009

LIE JT. Pulmonary peliosis. Arch Pathol Lab Med 1985 109:878-879.

 

LINDROTH Y, HANSEN B, HOLST R. Sakroiliit och missbruk av anabola steroider. Läkartidningen 1989 86:3369-3370.

LIOW RYL, TAVARES S. Bilateral rupture of the quadriceps tendon associated with anabolic steroids. Br J Sports Med 1995 29:77-79.

 

LOWDELL CP, MURRAY-LYON IM. Reversal of liver damage due to long term methyltestosterone and safety of non-17 alpha-alkylated androgens. BMJ 1985 291:637 .

LOWE GDO, THOMSON JE, REAVEY MM, FORBES CD, PRENTICE CRM. Mesterolone: thrombosis during treatment, and a study of its prothrombotic effects. Br J Clin Pharmac 1979 7:107-109.

 

LUKE JL, FARB A, VIRMANI R, SAMPLE RH. Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: pathological and toxicological findings. J Forensic Sci 1990 35:1441-1447.

 

LYNGBERG KK. Myokardie infarkt og død af bodybuilder behandlet med anabole steroide. Ugeskr Laeger 1991 153:587-588 .

 

MALARKEY WB, STRAUSS RH, LEIZMAN DJ, LIGGETT M, DEMERS LM. Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids. Am J Obstet Gynecol 1991 165:1385-1390.

 

MAROPIS C, YESALIS CE. Case report – intramuscular absess. Another anabolic steroid danger. Physician Sportsmed 1994 22:105-110.

 

MATSUMOTO AM. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and prallel dosesependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. J Clin Endocrinol Metab 1990 70:282-287.

 

MAUSS J, BÖRSCH G, BORMACHER K, RICHTER E, LEYENDECKER G, NOCKE W. Effect of long-term testosterone oenanthate administration on male reproductive function: clinical evaluation, serum FSH, LH, stestosterone, and seminal fluid analyses in normal men. Acta Endocrinol 1975 78:373-384.

 

MCNUTT RA, FERENCHICK GS, KIRLIN PC, HAMLIN NJ. Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol 1988 62:164.

 

MELCHERT RB, WELDER AA. Cardiovascular effects of androgenic-anabolic steroids. Med Sci Sports Exerc 1995 27:1252-1262.

 

MERKLE T, LANDTHALER M, BRAUN-FALCO O. Acne-conglobata-artige, exazerbation einer acne vulgaris nach einnahme von anabolika und vitamin-B-komplex-haltigen präparaten. Hautarzt 1990 41:280-282.

 

MEWIS C, SPYRIDOPOULOS I, KÜHLKAMP V, SEIPEL L. Manifestation of severe coronary heart disease after anabolic drug use. Clin Cardiol 1996 19:153-155.

 

MEYER WJ, FINKELSTEIN JW, STUART CA, WEBB A, SMITH ER, PAYER AF, WALKER PA. Physical and hormonal evaluation of transsexual patients during hormonal therapy. Arch Sex Behav 1981 10:347-356.

 

MILES JW, GRANA WA, EGLE D, MIN K-W, CHITWOOD J. The effect of anabolic steroids on the biomechanical and histological properties of rat tendon. J Bone Joint Surg 1992 74:411-422.

 

MOCHIZUKI RM, RICHTER KJ. Cardiomyopathy and cerebrovascular accident associated with anabolic-androgenic steroid use. Physician Sportsmed 1988 16:109-114.

 

MONTINE TJ, GAEDE JT. Massive pulmonary embolus and anabolic steroid abuse. JAMA 1992 267:2328-2329.

 

NADELL J, KOSEK J. Peliosis hepatis. Twelwe cases associated with oral androgen therapy. Arch Pathol Lab Med 1977 101:405-410 .

 

NAGELBERG SB, LAUE L, LORIAUX DL, LIU L, SHERINS RJ. Cerebrovascular accident associated with testosterone therapy in a 21-year-old hypogonadal man. N Engl J Med 1986 314:649-650.

 

NILSSON LR, SÖDERHJELM L. Female non-adrenal pseudohermaphroditism. Acta Paediatrica 1958 47:603-610.

 

OVERLY WL, DANKOFF JA, WANG BK, SINGH UD. Androgens and hepatocellular carcinoma in an athlete. Ann Intern Med 1984 100:158-159.

 

PACHE TD, CHADHA S, GOOREN LJ, HOP WC, JAARSMA KW, DOMMERHOLT HB, FAUSER BC. Ovarian morphology in long-term androgene-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? Histopathology 1991 19:445-452.

 

PALACIOS A, McCLURE RD, CAMPFIELD A, SWERDLOFF RS. Effect of testosterone enanthate on testis size. J Urology 1981 126:46-47.

 

PETERA V, BOBEK K, LAHN V. Serum transaminase (GOT, GPT) and lactic dehydrogenase activity during treatment with methyl testosterone. Clin Chim Acta 1962 7:604-606.

 

PLAUS WJ, HERMANN G. The surgical management of superficial infections caused by atypical mycobacteria. Surgery 1991 110:99-103.

 

POLDERMAN KH, GOOREN LJ, ASSCHEMAN H, BAKKER A, HEINE RJ. Metab 1994 79:265-271 .

 

POPE HG, KATZ DL. Psychiatric and medical effects of anabolic-androgenic steroid use –a controlled study of 160 athletes. Arch Gen Psychiatry 1994 51:375-382.

 

PRAT J, GRAY GF, STOLLEY PD, COLEMAN JW. Wilms tumor in an adult associated with androgen abuse. JAMA 1977 237: 2322-2323.

 

RASTAD J, JOBORN H, LJUNGHALL S, AKERSTROM G. Gluteal infection in weight lifters after injection of anabolic steroids. Läkartidningen 1985 82:3407.

 

RESCHINI E, GIUSTINA G, D’ALBERTON A, CANDIANI GB. Compensation for medical mishap. Lancet 1985 1226.

 

ROBERTS JT, ESSENHIGH DM. Adenocarcinoma of prostate in 40-year-old body-builder. Lancet 1986 742.

 

ROCKHOLD RW. Cardiovascular toxicity of anabolic steroids. Ann Rev Pharma Toxicol 1993 33:497-520.

 

ROGOL AD, MARTHA PM Jr, BILZZARD RM. Anabolic-androgenic steroids profoundly affect growth at puberty in boys. In: Anabolic Steroid Abuse, NIDA Res Monogr 102, Lin GC, Erinoff L (eds), Rockville Maryland, USA. 1990 102:187-196.

 

SAMDAL F, KLEPPE G, AMLAND PF, ABYHOLM F. Surgical treatment of gynaecomastia. Five years’ experience with liposuction. Scand J Plast Reconstr Hand Surg 1994 28:123-130.

 

SCOTT MJ, SCOTT MJ Jr. HIV infection associated with injections of anabolic steroids. JAMA 1989 262:207-208.

 

SCOTT MJ Jr, SCOTT MJ III, SCOTT AM. Linear keloids resulting from abuse of anabolic androgenic steroid drugs. Cutis 1994 53:41-43.

 

SHIOZAWA Z, TSUNODA S, NODA A, SAITO M, YAMADA H. Cerebral hemorrhagic infarction associated with anabolic steroid therapy for hypoplastic anemia. Angiology 1986 37:725-730.

 

SHIOZAWA Z, YAMADA H, MABUCHI C, HOTTA T, SAITO M, SABUE I, HUANG YP. Superior sagittal sinus thrombosis associated with androgen therapy for hypoplastic anemia. Ann Neurol 1982 12:578-580 .

 

SKLAREK HM, MANTOVANI RP, ERENS E, HEISLER D, NIEDERMAN MS, FEIN AM. AIDS in a bodybuilder using anabolic steroids. N Engl J Med 1984 311:1701.

 

STANNARD JP, BUCKNELL AL. Rupture of the triceps tendon associated with steroid injections. Am J Sports Med 1993 21:482-485.

 

STRAUSS RH, LIGGETT MT, LANESE RR. Anabolic steroid use perceived effects in ten weight-trained women athletes. JAMA 1985 253:2871-2873 .

 

STRAUSS RH, YESALIS CE. Additional effects of anabolic steroids on women. In: Anabolic Steroids in Sport and Exercise, Yesalis CH (ed), Human Kinetics Publishers. Champaign Illinois, USA. 1993 pp 151-159.

 

SWERDLOFF RS, PALACIOS A, McCLURE RD, CAMPFIELD LA, BROSMAN SA. Male contraception: Clinical assessment of chronic administration of testosterone enanthate. Int J Androl 1978 Suppl 2 pp. 731-745.

 

SOE KL, SOE M, GLUUD CN. Liver pathology associated with anabolic androgenic steroids. Ugeskr Laeger 1994 156:2585-2588.

 

VENERI RJ, GORDON SC. Anabolic steroid-induced cholestasis: choleretic response to corticosteroids. J Clin Gastroenterol 1988 10:467-468.

 

VISURI T, LINDHOLM H. Bilateral distal tendon avulsions with use of anabolic steroids. Med Sci Sports Exerc 1994 26:941-944.

 

WAKABAYASHI T, ONDA H, TADA T, IIJIMA M, ITOH Y. High incidence af peliosis hepatis in autopsy cases of aplastic anemia with special reference to anabolic steroid therapy. Acta Pathol Jpn 1984 34:1079-1086.

 

WALLACE EM, GOW SM, WU FCW. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations. J Clin Endocrinol Metab 1993 77:290-293.

 

WEMYSS-HOLDEN SA, HAMDY FC, HASTIE KJ. Steroid abuse in athletes, prostatic enlargement and bladder outflow obstruction-is there a relationship? Br J Urol 1994 74:476-478.

 

WESTABY D, OGLE SJ, PARADINAS FJ, RANDELL JB, MURRAY-LYON IM. Liver damage from long-term methyltestosterone. Lancet 1977 2:261-263.

 

WHO (World Health Organisation) task force on methods for the regulation on male fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 1990 336:955-959.

 

WU FCW, FARLEY TMM, PEREGOUDOV A, WAITES GMH. Effects on testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. Fertil Steril 1996 65:626-636.

 

YOSHIDA EM, ERB SR, SCUDAMORE CH, OWEN DA. Severe cholestasis and jaundice secondary to an esterified testosterone, a non-C17 alkylated anabolic steroid. J Clin Gastroenterol 1994 18:268-270.